Medicare Part D will now pay for Wegovy (semaglutide) to help millions of overweight people reduce their risk of heart attacks and strokes.
Diagnostic mistakes are common, often leading to permanent disability and death. A study says nearly 1 out of 5 patients are misdiagnosed.
Adopting a healthy eating pattern over the years reduces your chance of a heart attack or stroke by about 20 percent.